OTC Markets OTCQB - Delayed Quote USD

Willow Biosciences Inc. (CANSF)

Compare
0.0200
+0.0200
(0.00%)
As of January 24 at 3:41:24 PM EST. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,869.0000
1,172.0000
821.0000
133.0000
10.0000
Operating Expense
10,534.0000
14,649.0000
19,221.0000
23,307.0000
16,856.0000
Operating Income
-7,665.0000
-13,477.0000
-18,400.0000
-23,174.0000
-16,846.0000
Net Non Operating Interest Income Expense
-158.0000
125.0000
274.0000
387.0000
115.0000
Other Income Expense
440.0000
318.0000
3,365.0000
16,647.0000
-17,215.0000
Pretax Income
-7,383.0000
-13,034.0000
-14,761.0000
-6,140.0000
-33,946.0000
Tax Provision
332.0000
-5.0000
53.0000
--
--
Net Income Common Stockholders
-7,715.0000
-13,029.0000
-14,814.0000
-6,140.0000
-33,946.0000
Diluted NI Available to Com Stockholders
-7,715.0000
-13,029.0000
-14,814.0000
-6,140.0000
-33,946.0000
Basic EPS
-0.05
-0.10
-0.12
-0.05
-0.41
Diluted EPS
-0.05
-0.10
-0.12
-0.05
-0.41
Basic Average Shares
130,030.1300
124,243.4920
123,660.0800
119,987.6800
81,994.0920
Diluted Average Shares
130,030.1300
124,243.4920
123,660.0800
119,987.6800
81,994.0920
Total Operating Income as Reported
-7,225.0000
-13,182.0000
-18,393.0000
-23,330.0000
-23,061.0000
Total Expenses
10,534.0000
14,649.0000
19,221.0000
23,307.0000
16,856.0000
Net Income from Continuing & Discontinued Operation
-7,715.0000
-13,029.0000
-14,814.0000
-6,140.0000
-33,946.0000
Normalized Income
-8,089.0000
-13,346.8780
-17,297.0335
-22,787.0000
-16,731.0000
Interest Income
--
267.0000
300.0000
414.0000
155.0000
Interest Expense
--
142.0000
26.0000
27.0000
40.0000
Net Interest Income
-158.0000
125.0000
274.0000
387.0000
115.0000
EBIT
-6,952.0000
-12,892.0000
-14,735.0000
-6,113.0000
-33,906.0000
EBITDA
-5,556.0000
-11,061.0000
-12,089.0000
-2,921.0000
-30,724.0000
Reconciled Depreciation
1,396.0000
1,831.0000
2,646.0000
3,192.0000
3,182.0000
Net Income from Continuing Operation Net Minority Interest
-7,715.0000
-13,029.0000
-14,814.0000
-6,140.0000
-33,946.0000
Total Unusual Items Excluding Goodwill
440.0000
318.0000
3,365.0000
16,647.0000
-17,215.0000
Total Unusual Items
440.0000
318.0000
3,365.0000
16,647.0000
-17,215.0000
Normalized EBITDA
-5,996.0000
-11,379.0000
-15,454.0000
-19,568.0000
-13,509.0000
Tax Rate for Calcs
0.0002
0.0000
0.0003
--
--
Tax Effect of Unusual Items
66.0000
0.1220
881.9665
--
--
12/31/2020 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VEXT.CN Vext Science, Inc.
0.1700
+3.03%
 
AVCNF Avicanna Inc.
0.2152
0.00%
 
CPTR.CN Captor Capital Corp.
0.8900
0.00%
 
NWPN The Now Corporation
0.0001
0.00%
 
MYCO.CN Mydecine Innovations Group Inc.
0.0100
0.00%
 
GCAN The Greater Cannabis Company, Inc.
0.0007
0.00%
 
SBBCF Simply Better Brands Corp.
0.8100
0.00%
 
CNTMF Cansortium Inc.
0.0717
-3.11%
 
JUSH.CN Jushi Holdings Inc.
0.4500
-6.25%
 
TRUFF Red Light Holland Corp.
0.0321
-8.81%